Saccharomyces boulardii inhibits water and electrolytes changes induced by castor oil in the rat colon

Digestive Diseases and Sciences

Volumn 50, Issue 11, 2005, Pages 2183-2190

  Girard, Philippe ^a   Pansart, Yannick ^a   Coppe, Marie Claude ^a   Gillardin, Jean Marie ^a  

^a Service de Pharmacologie   (France)

Author keywords

Castor oil; Colon; Electrolyte; Saccharomyces boulardii; Secretion; Water

Indexed keywords

CASTOR OIL; CHLORIDE; ELECTROLYTE; POTASSIUM; PROBIOTIC AGENT; SODIUM; WATER;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; COLON; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SACCHAROMYCES BOULARDII; SECRETION; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIDIARRHEALS; ATROPINE; CASTOR OIL; COLON; DIARRHEA; ELECTROLYTES; LOPERAMIDE; MALE; RATS; RATS, WISTAR; SACCHAROMYCES; WATER;

EID: 27144508062     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-3029-3     Document Type: Article

References (40)

1. Mcfarland LV, Bernasconi P: Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb Ecol Health Dis 6:157-171, 1993
2. Periti P, Tonelli F: Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii. J Chemother 13:473-493, 2001
3. Surawicz CM, Elmer GW, Speelman P, Mcfarland LV, Chinn J, van Belle G: Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96:981-988, 1989
4. Mcfarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL: Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 90:439-448, 1995
5. Mcfarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z: A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271:1913-1918, 1994
6. Surawicz CM, Mcfarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen K, Borjal D, Elmer GW: The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31:1012-1017, 2000
7. Buts JP, Corthier G, Delmee M: Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. J Pediatr Gastroenterol Nutr 16:419-425, 1993
8. Plein K, Hotz J: Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea - a pilot study. Z Gastroenterol 31:129-134, 1993
9. Massot J, Sanchez O, Couchy R, Astoin J, Parodi AL: Bacterio- pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamster. Arzneimittelforschung 34:794-797, 1984
10. Toothaker RD, Elmer GW/Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii. Antimicrob Agents Chemother 26:552-556, 1984
11. Corthier G, Dubos F, Ducluzeau R: Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Can J Microbiol 32:894-896, 1986
12. Girard P, Pansart Y, Lorette I, Gillardin JM: Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats. Dig Dis Sci 48:770-774, 2003
13. Gaginella TS, Phillips SF: Ricinoleic acid: current view of an ancient oil. Am J Dig Dis 20:1171-1177, 1975
14. Gaginella TS, Bass P: Laxatives: an update on mechanism of action. Life Sci 23:1001-1009, 1978
15. Mascolo N, Izzo AA, Barbato F, Capasso F: Inhibitors of nitric oxide synthetase prevent castor-oil-induced diarrhoea in the rat. Br J Pharmacol 108:861-864, 1993
16. Beubler E, Juan H: Effect of ricinoleic acid and other laxatives on net water flux and prostaglandin E release by the rat colon. J Pharm Pharmacol 31:681-685, 1979
17. Simon GL, Gorbach SL: The human intestinal microflora. Dig Dis Sci 31(Suppl 9):147S-162S, 1986
18. Wilson KH: The gastrointestinal microflora. In T Yamada (eds). Textbook of Gastroenterology, 2nd edn. Philadelphia: JB Lippincott Company, 1995, pp 607-618
19. Robert A, Nezamis JE, Lancaster C, Hanchar AJ, Klepper MS: Enteropooling assay: a test for diarrhea produced by prostaglandins. Prostaglandins 11:809-828, 1976
20. Gaginella TS, Mascolo N, Izzo AA, Autore G, Capasso F: Nitric oxide as a mediator of bisacodyl and phenolphthalein laxative action: induction of nitric oxide synthase. J Pharmacol Exp Ther 270:1239-1245, 1994
21. Mascolo N, Gaginella TS, Izzo AA, Di Carlo G, Capasso F: Nitric oxide involvement in sodium choleate-induced fluid secretion and diarrhoea in rats. Eur J Pharmacol 264:21-26, 1994
22. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110, 1983
23. Van Hoestenberghe A, De Witte P, Geboes K, Eyssen H, Nijs G, Lemli J: The effect of rhein and rhein anthrone on intestinal fluid transport and on large intestine transit in germ-free rats. Eur J Pharmacol 212:121-123, 1992
24. Kunzelmann K, Mall M: Electrolyte Transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82:245-289, 2002
25. Mascolo N, Izzo AA, Autore G, Barbato F, Capasso F: Nitric oxide and castor oil-induced diarrhea. J Pharmacol Exp Ther 268:291-295, 1994
26. Kumar S, Dewan S, Sangraula H, Kumar VL: Anti-diarrhoeal activity of the latex of Calotropis procera. J Ethnopharmacol 76:115-118, 2001
27. Blehaut H, Massot J, Elmer GW, Levy RH: Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos 10:353-364, 1989
28. Izadnia F, Wong CT, Kocoshis SA: Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat. Dig Dis Sci 43:2055-2060, 1998
29. Krammer M, Karbach U: Antidiarrheal action of the yeast Saccharomyces boulardii in the rat small and large intestine by stimulating chloride absorption. Z Gastroenterol 31(Suppl 4):73-77, 1993
30. Castagliuolo I, Lamont JT, Nikulasson ST, Pothoulakis C: Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun 64:5225-5232, 1995
31. Schroeder B, Winckler C, Failing K, Breves G: Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum. Dig Dis Sci 49:1311-1317, 2004
32. Kollaritsch H, Holst H, Grobara P, Wiedermann G: Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study. Fortschr Med 111:152-156, 1993
33. Saint-Marc T, Rossello-Prats L, Touraine JL: Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS. Ann Med Interne (Paris) 142:64-65, 1991
34. Martin SW, Heatherington AC, Elmer GW: Pharmacokinetics of biotherapeutic agents. In Elmer GW, McFarland LV and Surawicz CM (eds). Biotherapeutic Agents and Infectious Diseases. Totowa, NJ: Humana Press, 1999, pp 47-84
35. Czerucka D, Roux I, Rampal P: Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells. Gastroenterology 106:65-72, 1994
36. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG: 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959-4963, 1997
37. Izzo AA, Mascolo N, Capasso F: Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci 43:1605-1620, 1998
38. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991
39. Tepperman BL, Brown JF, Whittle BJ: Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 265:0214-0218, 1993
40. Tamai H, Gaginella TS : Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon. Free Radic Res Commun 19:229-239, 1993